SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000850261-19-000058
Filing Date
2019-12-18
Accepted
2019-12-18 17:56:47
Documents
1
Period of Report
2019-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_157670979026532.html 4  
1 FORM 4 wf-form4_157670979026532.xml 4 4081
  Complete submission text file 0000850261-19-000058.txt   5569
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Issuer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O PHASE III MEDICAL, INC. 330 SOUTH SERVICE ROAD, SUITE 120 MELVILLE NY 11747
Business Address
Smith Robin L (Reporting) CIK: 0001365035 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36150 | Film No.: 191293605